As Biotechnology companies, TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Kura Oncology Inc. (NASDAQ:KURA) are our subject to contrast. And more ...
Feeds
23963 items (23963 unread) in 74 feeds
Acinar Cell Carcinoma
(130 unread)
Acinic Cell Carcinoma
(103 unread)
Adenoid Cystic Carcinoma
(437 unread)
Adrenal Gland Cancer
(2004 unread)
Ampulla Of Vater
(285 unread)
Anal Cancer
(2618 unread)
Angiosarcoma
(768 unread)
Appendix Cancer
(325 unread)
Bile Duct Cancer
(2729 unread)
Brain and CNS
(3424 unread)
Carcinoid
(1062 unread)
Endocrine/Neuroendocrine
(2987 unread)
Gall Bladder Cancer
(1092 unread)
Hemangioendothelioma
(216 unread)
Hepatoblastoma
(414 unread)
Pancreas
(302 unread)
Phyllodes
(205 unread)
PMP and Mucinous Tumors
(233 unread)
Rhabdomyosarcoma
(873 unread)
Sarcoma
(3756 unread)
Google - Angiosarcoma (100 unread)
-
Comparison of TRACON Pharmaceuticals Inc. (TCON) and Kura Oncology Inc. (NASDAQ:KURA) - The NBO News
Posted: May 22nd, 2019, 8:24pm GMT
Comparison of TRACON Pharmaceuticals Inc. (TCON) and Kura Oncology Inc. (NASDAQ:KURA) The NBO News -
Liver Cancer Molecular Diagnostics Market Size, Share | Industry Report 2025 - openPR
Posted: May 22nd, 2019, 12:07pm GMT
Liver Cancer Molecular Diagnostics Market Size, Share | Industry Report 2025 openPRThe global liver cancer molecular diagnostics market was valued at $115.3 Million in 2017 and is forecast to grow at a modest 13.7 % CAGR between 2018 and ...
-
Angiosarcomas Treatment Market: Adoption of Innovative Offerings To Boost Returns On Investment - Gator Ledger
Posted: May 22nd, 2019, 11:27am GMT
Angiosarcomas Treatment Market: Adoption of Innovative Offerings To Boost Returns On Investment Gator LedgerIndustrial Growth Forecast Report Playground Angiosarcomas Treatment Market 2018-2026: The Global Angiosarcomas Treatment Market Report provides ...
-
Contrasting of TRACON Pharmaceuticals Inc. (TCON) and Axsome Therapeutics Inc. (NASDAQ:AXSM) - CryptoCoinsTribune
Posted: May 22nd, 2019, 4:52am GMT
Contrasting of TRACON Pharmaceuticals Inc. (TCON) and Axsome Therapeutics Inc. (NASDAQ:AXSM) CryptoCoinsTribuneThis is a contrast between TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Axsome Therapeutics Inc. (NASDAQ:AXSM) based on their institutional ...
-
TRACON Pharmaceuticals Inc. (TCON)'s Financial Results Comparing With BeyondSpring Inc. (NASDAQ:BYSI) - The EN Herald
Posted: May 22nd, 2019, 10:43pm GMT
TRACON Pharmaceuticals Inc. (TCON)'s Financial Results Comparing With BeyondSpring Inc. (NASDAQ:BYSI) The EN HeraldTRACON Pharmaceuticals Inc. (NASDAQ:TCON) and BeyondSpring Inc. (NASDAQ:BYSI), are influenced by compare since they are both players in the ...
-
Comparing of TRACON Pharmaceuticals Inc. (TCON) and Fortress Biotech Inc. (NASDAQ:FBIO) - CryptoCoinsTribune
Posted: May 21st, 2019, 8:30pm GMT
Comparing of TRACON Pharmaceuticals Inc. (TCON) and Fortress Biotech Inc. (NASDAQ:FBIO) CryptoCoinsTribuneAs Biotechnology companies, TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Fortress Biotech Inc. (NASDAQ:FBIO) are our subject to compare. And more ...
-
Contrasting of Aclaris Therapeutics Inc. (ACRS) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) - The EN Herald
Posted: May 21st, 2019, 2:35pm GMT
Contrasting of Aclaris Therapeutics Inc. (ACRS) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) The EN HeraldAclaris Therapeutics Inc. (NASDAQ:ACRS) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) are two firms in the Biotechnology that compete against each ...
-
What Will Happen to TRACON Pharmaceuticals, Inc. (TCON) Next? The Stock Formed a Several Months Bearish Double Bottom Chart Pattern - The MAK Daily
Posted: May 21st, 2019, 8:48am GMT
What Will Happen to TRACON Pharmaceuticals, Inc. (TCON) Next? The Stock Formed a Several Months Bearish Double Bottom Chart Pattern The MAK DailyThe chart of TRACON Pharmaceuticals, Inc. (TCON) shows a double bottom with $0.70 target or 8.00 % below today's $0.76 share price. The 7 months chart ...
-
Angiosarcomas Treatment Market – Global Industry, Size, Share And Forecast 2018-2026 - Veteran's Vista
Posted: May 21st, 2019, 8:46am GMT
Angiosarcomas Treatment Market – Global Industry, Size, Share And Forecast 2018-2026 Veteran's VistaAngiosarcomas Treatment Market is drafted for providing the interested readers with the crucial information related to the Angiosarcomas Treatment industry.
-
Is Selling TRACON Pharmaceuticals, Inc. (TCON) Here a Winning Strategy? The Stock Formed Bearish Double Bottom Chart Pattern - Invest Tribune
Posted: May 21st, 2019, 8:24am GMT
Is Selling TRACON Pharmaceuticals, Inc. (TCON) Here a Winning Strategy? The Stock Formed Bearish Double Bottom Chart Pattern Invest TribuneThe chart of TRACON Pharmaceuticals, Inc. (TCON) shows a double bottom with $0.70 target or 8.00 % below today's $0.76 share price. The 7 months chart ...
-
New data on cancer disparities in Washington - Fred Hutch News Service
Posted: May 20th, 2019, 5:29pm GMT
New data on cancer disparities in Washington Fred Hutch News ServiceWhere a person lives has a big impact on whether they will live following a cancer diagnosis in our state, according to new data released by researchers at the ...
-
Analysts Anticipate TRACON Pharmaceuticals Inc (TCON) Will Post Earnings of -$0.20 Per Share - Tech Know Bits
Posted: May 19th, 2019, 4:43pm GMT
Analysts Anticipate TRACON Pharmaceuticals Inc (TCON) Will Post Earnings of -$0.20 Per Share Tech Know BitsWall Street brokerages forecast that TRACON Pharmaceuticals Inc (NASDAQ:TCON) will post earnings per share (EPS) of ($0.20) for the current quarter, ...
-
Zacks Investment Research Downgrades TRACON Pharmaceuticals (TCON) to Sell - Tech Know Bits
Posted: May 18th, 2019, 11:48am GMT
Zacks Investment Research Downgrades TRACON Pharmaceuticals (TCON) to Sell Tech Know BitsTRACON Pharmaceuticals (NASDAQ:TCON) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued to ...
-
TRACON Pharmaceuticals (TCON) Sees Large Volume Increase - Tech Know Bits
Posted: May 17th, 2019, 8:52pm GMT
TRACON Pharmaceuticals (TCON) Sees Large Volume Increase Tech Know BitsShares of TRACON Pharmaceuticals Inc (NASDAQ:TCON) saw unusually-high trading volume on Friday . Approximately 1008522 shares were traded during ...
-
Head-To-Head Comparison: TRACON Pharmaceuticals (TCON) vs. Gilead Sciences (GILD) - Tech Know Bits
Posted: May 17th, 2019, 6:25am GMT
Head-To-Head Comparison: TRACON Pharmaceuticals (TCON) vs. Gilead Sciences (GILD) Tech Know BitsGilead Sciences (NASDAQ:GILD) and TRACON Pharmaceuticals (NASDAQ:TCON) are both medical companies, but which is the better stock? We will contrast ...
-
TRACON Pharmaceuticals (TCON) Posts Earnings Results - Mayfield Recorder
Posted: May 16th, 2019, 11:41am GMT
TRACON Pharmaceuticals (TCON) Posts Earnings Results Mayfield RecorderTRACON Pharmaceuticals (NASDAQ:TCON) issued its quarterly earnings data on Tuesday. The biopharmaceutical company reported ($0.24) earnings per ...
-
-$0.16 Earnings Per Share Expected for TRACON Pharmaceuticals Inc (TCON) This Quarter - Rockland Register
Posted: May 16th, 2019, 10:09am GMT
-$0.16 Earnings Per Share Expected for TRACON Pharmaceuticals Inc (TCON) This Quarter Rockland RegisterWall Street brokerages predict that TRACON Pharmaceuticals Inc (NASDAQ:TCON) will post earnings per share (EPS) of ($0.16) for the current fiscal quarter, ...
-
Contrasting of TRACON Pharmaceuticals Inc. (TCON) and Curis Inc. (NASDAQ:CRIS) - The EN Herald
Posted: May 16th, 2019, 9:13am GMT
Contrasting of TRACON Pharmaceuticals Inc. (TCON) and Curis Inc. (NASDAQ:CRIS) The EN HeraldWe are comparing TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Curis Inc. (NASDAQ:CRIS) on their profitability, analyst recommendations, risk, ...
-
Should Investors Turn Their Attention to Athenex (NASDAQ:ATNX)? BidaskScore Has Just Upgraded the Stock - The MAK Daily
Posted: May 16th, 2019, 5:00am GMT
Should Investors Turn Their Attention to Athenex (NASDAQ:ATNX)? BidaskScore Has Just Upgraded the Stock The MAK DailyTrading of shares of Athenex (NASDAQ:ATNX) will be interesting to watch this afternoon as BidaskScore raised the stock to a “Hold”. The stock increased 1.59% ...
-
Analysts Anticipate TRACON Pharmaceuticals Inc (TCON) Will Post Earnings of -$0.19 Per Share - Tech Know Bits
Posted: May 15th, 2019, 3:15pm GMT
Analysts Anticipate TRACON Pharmaceuticals Inc (TCON) Will Post Earnings of -$0.19 Per Share Tech Know BitsBrokerages predict that TRACON Pharmaceuticals Inc (NASDAQ:TCON) will report ($0.19) earnings per share for the current fiscal quarter, according to Zacks.
-
Comparison of TRACON Pharmaceuticals Inc. (TCON) and Selecta Biosciences Inc. (NASDAQ:SELB) - The NBO News
Posted: May 15th, 2019, 2:44pm GMT
Comparison of TRACON Pharmaceuticals Inc. (TCON) and Selecta Biosciences Inc. (NASDAQ:SELB) The NBO NewsTRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Selecta Biosciences Inc. (NASDAQ:SELB), are influenced by contrast since they are both players in the.
-
TRACON Pharmaceuticals (TCON) Announces Quarterly Earnings Results - Tech Know Bits
Posted: May 15th, 2019, 1:15pm GMT
TRACON Pharmaceuticals (TCON) Announces Quarterly Earnings Results Tech Know BitsTRACON Pharmaceuticals (NASDAQ:TCON) announced its quarterly earnings data on Tuesday. The biopharmaceutical company reported ($0.24) earnings per ...
-
Contrasting of TRACON Pharmaceuticals Inc. (TCON) and Novavax Inc. (NASDAQ:NVAX) - CryptoCoinsTribune
Posted: May 15th, 2019, 5:32am GMT
Contrasting of TRACON Pharmaceuticals Inc. (TCON) and Novavax Inc. (NASDAQ:NVAX) CryptoCoinsTribuneAs Biotechnology businesses, TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Novavax Inc. (NASDAQ:NVAX), are affected by contrast. This especially ...
-
TRACON Pharmaceuticals Inc. (TCON) and Osmotica Pharmaceuticals plc (NASDAQ:OSMT) Comparison side by side - The NBO News
Posted: May 15th, 2019, 11:35pm GMT
TRACON Pharmaceuticals Inc. (TCON) and Osmotica Pharmaceuticals plc (NASDAQ:OSMT) Comparison side by side The NBO NewsBoth TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Osmotica Pharmaceuticals plc (NASDAQ:OSMT) are each other's competitor in the Biotechnology ...
-
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and Anchiano Therapeutics Ltd (NASDAQ:ANCN)'s results - CryptoCoinsTribune
Posted: May 15th, 2019, 11:31pm GMT
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and Anchiano Therapeutics Ltd (NASDAQ:ANCN)'s results CryptoCoinsTribuneTRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Anchiano Therapeutics Ltd (NASDAQ:ANCN) compete with each other in the Biotechnology sector.
-
Angiosarcomas Treatment Market Development and Forecast 2018-2026 - Truth Daily Mirror
Posted: May 15th, 2019, 10:40pm GMT
Angiosarcomas Treatment Market Development and Forecast 2018-2026 Truth Daily MirrorCMI Present a published report on “Global Angiosarcomas Treatment Market Industry Analysis, Growth and Forecast 2018 – 2026” delivering key insights and ...
-
Comparison of TRACON Pharmaceuticals Inc. (TCON) and Innovate Biopharmaceuticals Inc. (NASDAQ:INNT) - The EN Herald
Posted: May 14th, 2019, 8:29pm GMT
Comparison of TRACON Pharmaceuticals Inc. (TCON) and Innovate Biopharmaceuticals Inc. (NASDAQ:INNT) The EN HeraldTRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Innovate Biopharmaceuticals Inc. (NASDAQ:INNT) compete with each other in the Biotechnology sector.
-
TRACON Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Corporate Update - GlobeNewswire
Posted: May 14th, 2019, 6:03pm GMT
TRACON Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswireSAN DIEGO, May 14, 2019 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the ...
-
Ingalls & Snyder Raised Alexion Pharmaceuticals (ALXN) Holding; Athenex (ATNX) Sellers Decreased By 2.6% Their Shorts - The EN Herald
Posted: May 14th, 2019, 9:51am GMT
Ingalls & Snyder Raised Alexion Pharmaceuticals (ALXN) Holding; Athenex (ATNX) Sellers Decreased By 2.6% Their Shorts The EN HeraldIngalls & Snyder Llc increased Alexion Pharmaceuticals Inc (ALXN) stake by 217.14% reported in 2018Q4 SEC filing. Ingalls & Snyder Llc acquired 15367 ...
-
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and Xencor Inc. (NASDAQ:XNCR)'s results - CryptoCoinsTribune
Posted: May 14th, 2019, 3:41am GMT
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and Xencor Inc. (NASDAQ:XNCR)'s results CryptoCoinsTribuneThis is a contrast between TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Xencor Inc. (NASDAQ:XNCR) based on their profitability, analyst ...
-
TRACON Pharmaceuticals Inc. (TCON)'s Financial Results Comparing With Vascular Biogenics Ltd. (NASDAQ:VBLT) - CryptoCoinsTribune
Posted: May 13th, 2019, 9:41pm GMT
TRACON Pharmaceuticals Inc. (TCON)'s Financial Results Comparing With Vascular Biogenics Ltd. (NASDAQ:VBLT) CryptoCoinsTribuneBoth TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Vascular Biogenics Ltd. (NASDAQ:VBLT) compete on a level playing field in the Biotechnology ...
-
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and Aclaris Therapeutics Inc. (NASDAQ:ACRS)'s results - The NBO News
Posted: May 13th, 2019, 9:25pm GMT
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and Aclaris Therapeutics Inc. (NASDAQ:ACRS)'s results The NBO NewsSince TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Aclaris Therapeutics Inc. (NASDAQ:ACRS) are part of the Biotechnology industry, they are ...
-
Angiosarcomas Treatment Market Growth and Price with Future projections till 2026 - Business Herald
Posted: May 13th, 2019, 7:49pm GMT
Angiosarcomas Treatment Market Growth and Price with Future projections till 2026 Business HeraldCoherent Market Insights released a new market study on 2018-2026 Angiosarcomas Treatment Market with 100+ market data Tables, Pie Chat, Graphs ...
-
TRACON Pharmaceuticals (TCON) to Release Earnings on Tuesday - Rockland Register
Posted: May 13th, 2019, 8:42am GMT
TRACON Pharmaceuticals (TCON) to Release Earnings on Tuesday Rockland RegisterTRACON Pharmaceuticals (NASDAQ:TCON) will post its quarterly earnings results after the market closes on Tuesday, May 14th. Analysts expect TRACON ...
-
TRACON Pharmaceuticals (TCON) to Release Quarterly Earnings on Tuesday - Tech Know Bits
Posted: May 12th, 2019, 8:05am GMT
TRACON Pharmaceuticals (TCON) to Release Quarterly Earnings on Tuesday Tech Know BitsTRACON Pharmaceuticals (NASDAQ:TCON) is scheduled to be announcing its earnings results after the market closes on Tuesday, May 14th. Analysts expect ...
-
TRACON Pharmaceuticals Inc. (TCON) and EyeGate Pharmaceuticals Inc. (NASDAQ:EYEG) Comparing side by side - The EN Herald
Posted: May 11th, 2019, 5:00am GMT
TRACON Pharmaceuticals Inc. (TCON) and EyeGate Pharmaceuticals Inc. (NASDAQ:EYEG) Comparing side by side The EN HeraldTRACON Pharmaceuticals Inc. (NASDAQ:TCON) and EyeGate Pharmaceuticals Inc. (NASDAQ:EYEG) compete with each other in the Biotechnology sector.
-
TRACON Pharmaceuticals Inc (TCON) Expected to Announce Earnings of -$0.19 Per Share - Mayfield Recorder
Posted: May 11th, 2019, 3:23am GMT
TRACON Pharmaceuticals Inc (TCON) Expected to Announce Earnings of -$0.19 Per Share Mayfield RecorderWall Street brokerages forecast that TRACON Pharmaceuticals Inc (NASDAQ:TCON) will post earnings of ($0.19) per share for the current quarter, Zacks reports ...
-
Athenex, Inc. (ATNX) CEO Johnson Lau on Q1 2019 Results - Earnings Call Transcript - Seeking Alpha
Posted: May 11th, 2019, 1:25am GMT
Athenex, Inc. (ATNX) CEO Johnson Lau on Q1 2019 Results - Earnings Call Transcript Seeking AlphaAthenex, Inc. (NASDAQ:ATNX) Q1 2019 Earnings Conference Call May 09, 2019, 08:00 AM ET Company Participants Tim McCarthy - Managing Director of ...
-
Athenex, Inc. (ATNX) CEO Johnson Lau on Q1 2019 Results - Earnings Call Transcript - Seeking Alpha
Posted: May 11th, 2019, 1:25am GMT
Athenex, Inc. (ATNX) CEO Johnson Lau on Q1 2019 Results - Earnings Call Transcript Seeking AlphaAthenex, Inc. (NASDAQ:ATNX) Q1 2019 Earnings Conference Call May 09, 2019, 08:00 AM ET Company Participants Tim McCarthy - Managing Director of ...
-
TRACON Pharmaceuticals Inc. (TCON) and Denali Therapeutics Inc. (NASDAQ:DNLI) Comparing side by side - CryptoCoinsTribune
Posted: May 10th, 2019, 9:43pm GMT
TRACON Pharmaceuticals Inc. (TCON) and Denali Therapeutics Inc. (NASDAQ:DNLI) Comparing side by side CryptoCoinsTribuneTRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Denali Therapeutics Inc. (NASDAQ:DNLI), are influenced by contrast since they are both players in the.
-
Athenex, Inc. (ATNX) Reaches $13.85 After 6.00% Up Move; US Global Investors (GROW)'s Sentiment Is 0.36 - The NBO News
Posted: May 10th, 2019, 3:36pm GMT
Athenex, Inc. (ATNX) Reaches $13.85 After 6.00% Up Move; US Global Investors (GROW)'s Sentiment Is 0.36 The NBO NewsThe stock of Athenex, Inc. (NASDAQ:ATNX) is a huge mover today! The stock increased 6.46% or $0.84 during the last trading session, reaching $13.85.
-
Solid Biosciences (SLDB) & TRACON Pharmaceuticals (TCON) Critical Survey - Mayfield Recorder
Posted: May 10th, 2019, 4:28am GMT
Solid Biosciences (SLDB) & TRACON Pharmaceuticals (TCON) Critical Survey Mayfield RecorderTRACON Pharmaceuticals (NASDAQ:TCON) and Solid Biosciences (NASDAQ:SLDB) are both small-cap medical companies, but which is the superior business ...
-
Athenex, Inc. (ATNX) Q1 2019 Earnings Call Transcript - Motley Fool
Posted: May 9th, 2019, 5:23pm GMT
Athenex, Inc. (ATNX) Q1 2019 Earnings Call Transcript Motley FoolATNX earnings call for the period ending March 31, 2019.
-
Critical Contrast: TRACON Pharmaceuticals (TCON) versus Gilead Sciences (GILD) - Tech Know Bits
Posted: May 9th, 2019, 12:31pm GMT
Critical Contrast: TRACON Pharmaceuticals (TCON) versus Gilead Sciences (GILD) Tech Know BitsTRACON Pharmaceuticals (NASDAQ:TCON) and Gilead Sciences (NASDAQ:GILD) are both medical companies, but which is the superior investment? We will ...
-
Athenex, Inc. Announces First Quarter 2019 Financial Results and Provides Corporate Update - GlobeNewswire
Posted: May 9th, 2019, 9:00am GMT
Athenex, Inc. Announces First Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswirePositive Phase 3 data for KX2-391 featured at 2019 AAD Annual Meeting. Promising early and complete response data reported for Oraxol in cutaneous ...
-
Athenex, Inc. Announces First Quarter 2019 Financial Results and Provides Corporate Update - GlobeNewswire
Posted: May 9th, 2019, 9:00am GMT
Athenex, Inc. Announces First Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswirePositive Phase 3 data for KX2-391 featured at 2019 AAD Annual Meeting. Promising early and complete response data reported for Oraxol in cutaneous ...
-
Athenex, Inc. Announces First Quarter 2019 Financial Results and Provides Corporate Update - Nasdaq
Posted: May 9th, 2019, 9:00am GMT
Athenex, Inc. Announces First Quarter 2019 Financial Results and Provides Corporate Update NasdaqPositive Phase 3 data for KX2-391 featured at 2019 AAD Annual Meeting. Promising early and complete response data reported for Oraxol in cutaneous.
-
Angiosarcomas Treatment Market Expected to Witness a Sustainable Growth by 2024 - Market Reporter
Posted: May 9th, 2019, 7:01am GMT
Angiosarcomas Treatment Market Expected to Witness a Sustainable Growth by 2024 Market ReporterRare and clinically highly variable, Sarcoma is a type of cancer that originates from mesenchymal cells transformation. Sarcoma defines as the major tumors, ...
-
Athenex, Inc. (ATNX) Q1 2019 Earnings Call Transcript - Yahoo Finance
Posted: May 9th, 2019, 5:00am GMT
Athenex, Inc. (ATNX) Q1 2019 Earnings Call Transcript Yahoo FinanceATNX earnings call for the period ending March 31, 2019.
-
Angiosarcomas Treatment Market Is Expected to Expand at an Impressive Rate by 2024 - Press Release - Digital Journal
Posted: May 8th, 2019, 5:06pm GMT
Angiosarcomas Treatment Market Is Expected to Expand at an Impressive Rate by 2024 - Press Release Digital JournalTransparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR's global and ...
-
TRACON Pharmaceuticals (TCON) Set to Announce Earnings on Tuesday - Finance Daily
Posted: May 8th, 2019, 11:23am GMT
TRACON Pharmaceuticals (TCON) Set to Announce Earnings on Tuesday Finance DailyTRACON Pharmaceuticals (NASDAQ:TCON) will be releasing its earnings data after the market closes on Tuesday, May 14th. Analysts expect TRACON ...
-
Analysts See $-0.45 EPS for Athenex, Inc. (ATNX); Penn Capital Management Co Has Increased Exelixis (EXEL) Holding - The NBO News
Posted: May 8th, 2019, 7:28am GMT
Analysts See $-0.45 EPS for Athenex, Inc. (ATNX); Penn Capital Management Co Has Increased Exelixis (EXEL) Holding The NBO NewsAnalysts expect Athenex, Inc. (NASDAQ:ATNX) to report $-0.45 EPS on May, 9 before the open.They anticipate $0.33 EPS change or 275.00% from last ...
-
Angiosarcomas Treatment Market with Outlook and Trends with Analysis By 2026 - Forex Tribune
Posted: May 8th, 2019, 7:12am GMT
Angiosarcomas Treatment Market with Outlook and Trends with Analysis By 2026 Forex TribuneAngiosarcomas Treatment Market Research Study provides detailed information about the key factors influencing the growth of the industry which include ...
-
Analysts Anticipate TRACON Pharmaceuticals Inc (TCON) Will Post Earnings of -$0.19 Per Share - Tech Know Bits
Posted: May 7th, 2019, 9:19pm GMT
Analysts Anticipate TRACON Pharmaceuticals Inc (TCON) Will Post Earnings of -$0.19 Per Share Tech Know BitsBrokerages predict that TRACON Pharmaceuticals Inc (NASDAQ:TCON) will report ($0.19) earnings per share for the current fiscal quarter, according to Zacks.
-
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and LogicBio Therapeutics Inc. (NASDAQ:LOGC)'s results - CryptoCoinsTribune
Posted: May 7th, 2019, 12:00pm GMT
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and LogicBio Therapeutics Inc. (NASDAQ:LOGC)'s results CryptoCoinsTribuneSince TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and LogicBio Therapeutics Inc. (NASDAQ:LOGC) are part of the Biotechnology industry, they are ...
-
Comparison of Therapix Biosciences Ltd. (TRPX) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) - The EN Herald
Posted: May 7th, 2019, 11:50am GMT
Comparison of Therapix Biosciences Ltd. (TRPX) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) The EN HeraldWe will be contrasting the differences between Therapix Biosciences Ltd. (NASDAQ:TRPX) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) as far as ...
-
Galapagos NV (GLPG)'s Financial Results Comparing With TRACON Pharmaceuticals Inc. (NASDAQ:TCON) - CryptoCoinsTribune
Posted: May 7th, 2019, 7:37am GMT
Galapagos NV (GLPG)'s Financial Results Comparing With TRACON Pharmaceuticals Inc. (NASDAQ:TCON) CryptoCoinsTribuneWe will be contrasting the differences between Galapagos NV (NASDAQ:GLPG) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) as far as risk, analyst.
-
Angiosarcomas Treatment Market Pegged for Robust Expansion by 2024 - Market Research Gazette
Posted: May 7th, 2019, 5:55am GMT
Angiosarcomas Treatment Market Pegged for Robust Expansion by 2024 Market Research GazetteRare and clinically highly variable, Sarcoma is a type of cancer that originates from mesenchymal cells transformation. Sarcoma defines as the major tumors, ...
-
Ken Handley | Obituaries - Lufkin Daily News
Posted: May 7th, 2019, 3:30am GMT
Ken Handley | Obituaries Lufkin Daily NewsKen Handley. Community member and dentist Ken Earl Handley will be missed. Born July 31, 1950, Ken grew up in Lufkin and never lost his affection for the ...
-
Neurotrope Inc. (NTRP) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Comparing side by side - CryptoCoinsTribune
Posted: May 6th, 2019, 9:19pm GMT
Neurotrope Inc. (NTRP) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Comparing side by side CryptoCoinsTribuneNeurotrope Inc. (NASDAQ:NTRP) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON), are influenced by compare since they are both players in the ...
-
Global Soft Tissue Sarcoma Treatment Market to Witness Stellar Revenue Growth Across Top Regional Pockets - Whopp News
Posted: May 6th, 2019, 3:15pm GMT
Global Soft Tissue Sarcoma Treatment Market to Witness Stellar Revenue Growth Across Top Regional Pockets Whopp NewsSarcoma are the type of cancer that develops from tissues such as nerves, muscles, fats, blood vessels and deep skin tissues. It occurs in the blood vessels, ...
-
Athenex, Inc. (ATNX) Reaches $12.46 After 8.00% Up Move; Pinnacle Financial Partners (PNFP) Has 1.2 Sentiment - The NBO News
Posted: May 6th, 2019, 1:15pm GMT
Athenex, Inc. (ATNX) Reaches $12.46 After 8.00% Up Move; Pinnacle Financial Partners (PNFP) Has 1.2 Sentiment The NBO NewsThe stock of Athenex, Inc. (NASDAQ:ATNX) is a huge mover today! The stock increased 23.12% or $2.34 during the last trading session, reaching $12.46.
-
Ken Handley | Obituaries - Lufkin Daily News
Posted: May 5th, 2019, 3:30am GMT
Ken Handley | Obituaries Lufkin Daily NewsKen Handley. Community member and dentist Ken Earl Handley will be missed. Born July 31, 1950, Ken grew up in Lufkin and never lost his affection for the ...
-
Wellington Shields Capital Management Cut Pilgrims Pride (PPC) Holding; Tracon Pharmaceuticals (TCON) Shorts Increased By 73.68% - CryptoCoinsTribune
Posted: May 4th, 2019, 2:46pm GMT
Wellington Shields Capital Management Cut Pilgrims Pride (PPC) Holding; Tracon Pharmaceuticals (TCON) Shorts Increased By 73.68% CryptoCoinsTribuneWellington Shields Capital Management Llc decreased Pilgrims Pride Corp (PPC) stake by 40.9% reported in 2018Q4 SEC filing. Wellington Shields Capital ...
-
Ken Handley | Obituaries - Lufkin Daily News
Posted: May 4th, 2019, 3:30am GMT
Ken Handley | Obituaries Lufkin Daily NewsCommunity member and dentist Ken Earl Handley will be missed. Born July 31, 1950, Ken grew up in Lufkin and never lost his affection for the place and its ...
-
Angiosarcomas Treatment Market Outlook To 2026: Top Companies In Market, Trends and Growth Factors - Ace Newz
Posted: May 4th, 2019, 1:11am GMT
Angiosarcomas Treatment Market Outlook To 2026: Top Companies In Market, Trends and Growth Factors Ace NewzThe Angiosarcomas Treatment market demand is anticipated to flourish during the forecast period 2018-2026. The report offers information related to import and ...
-
Athenex (ATNX) Announces 'Promising' Early and Complete Response Data from Study of Oraxol in Cutaneous Angiosarcoma - StreetInsider.com
Posted: May 3rd, 2019, 11:13am GMT
Athenex (ATNX) Announces 'Promising' Early and Complete Response Data from Study of Oraxol in Cutaneous Angiosarcoma StreetInsider.comGet instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here. Athenex, Inc. (NASDAQ: ATNX), a global ...
-
Athenex Announces Promising Early and Complete Response Data from a Clinical Study of Oraxol in Cutaneous Angiosarcoma - GlobeNewswire
Posted: May 3rd, 2019, 11:12am GMT
Athenex Announces Promising Early and Complete Response Data from a Clinical Study of Oraxol in Cutaneous Angiosarcoma GlobeNewswirePreliminary data show rapid, visible response to Oraxol monotherapy in the first seven subjects, including three complete responses.
-
$-0.17 EPS Expected for TRACON Pharmaceuticals, Inc. (TCON) - Invest Tribune
Posted: May 3rd, 2019, 9:52am GMT
$-0.17 EPS Expected for TRACON Pharmaceuticals, Inc. (TCON) Invest TribuneAnalysts expect TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) to report $-0.17 EPS on May, 8.They anticipate $0.29 EPS change or 63.04 % from last ...
-
Hanmi Pharm’s short gut syndrome drug granted orphan status in U.S. - Pulse News
Posted: May 3rd, 2019, 3:30am GMT
Hanmi Pharm’s short gut syndrome drug granted orphan status in U.S. Pulse NewsHanmi Pharm's LAPS GLP-2 Analog under investigation for the treatment of short bowel syndrome joined the U.S. Food and Drug Administration's list of orphan ...
-
Hanmi's short bowel syndrome treatment becomes orphan drug in US - Korea Biomedical Review
Posted: May 3rd, 2019, 12:42am GMT
Hanmi's short bowel syndrome treatment becomes orphan drug in US Korea Biomedical ReviewThe U.S. Food and Drug Administration has granted an orphan drug designation (ODD) status to Hanmi's HM15912, a drug candidate for short bowel syndrome.
-
What's in Tracon Pharmaceuticals Inc (NASDAQ:TCON) After Rise in Shorted Shares? - Invest Tribune
Posted: May 2nd, 2019, 4:23pm GMT
What's in Tracon Pharmaceuticals Inc (NASDAQ:TCON) After Rise in Shorted Shares? Invest TribuneThe stock of Tracon Pharmaceuticals Inc (NASDAQ:TCON) registered an increase of 73.68% in short interest. TCON's total short interest was 430200 shares in ...
-
Angiosarcomas Treatment Market Technological Advancements and Forecast 2018-2026 - Oak Tribune
Posted: May 2nd, 2019, 1:30pm GMT
Angiosarcomas Treatment Market Technological Advancements and Forecast 2018-2026 Oak TribuneAngiosarcomas Treatment Market: In-Depth Research On Market Dynamics, Emerging Growth Factors And Forecasts To 2018 – 2026. The report serves with ...
-
Analysts See $-0.17 EPS for TRACON Pharmaceuticals, Inc. (TCON) - Invest Tribune
Posted: May 2nd, 2019, 11:12am GMT
Analysts See $-0.17 EPS for TRACON Pharmaceuticals, Inc. (TCON) Invest TribuneAnalysts expect TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) to report $-0.17 EPS on May, 8.They anticipate $0.29 EPS change or 63.04 % from last ...
-
Comparing TRACON Pharmaceuticals (TCON) & Solid Biosciences (SLDB) - Mayfield Recorder
Posted: May 2nd, 2019, 10:27am GMT
Comparing TRACON Pharmaceuticals (TCON) & Solid Biosciences (SLDB) Mayfield RecorderTRACON Pharmaceuticals (NASDAQ:TCON) and Solid Biosciences (NASDAQ:SLDB) are both small-cap medical companies, but which is the better business?
-
Athenex, Inc. (ATNX) Trades at $9.44 After Triangle; Misonix (MSON)'s Sentiment Is 0.85 - CryptoCoinsTribune
Posted: May 2nd, 2019, 9:56am GMT
Athenex, Inc. (ATNX) Trades at $9.44 After Triangle; Misonix (MSON)'s Sentiment Is 0.85 CryptoCoinsTribuneMisonix Inc (MSON) investors sentiment decreased to 0.85 in 2018 Q4. It's down -2.32, from 3.17 in 2018Q3. The ratio dived, as 11 investment professionals ...
-
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and Oncolytics Biotech Inc. (NASDAQ:ONCY)'s results - CryptoCoinsTribune
Posted: May 1st, 2019, 9:31pm GMT
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and Oncolytics Biotech Inc. (NASDAQ:ONCY)'s results CryptoCoinsTribuneTRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Oncolytics Biotech Inc. (NASDAQ:ONCY) compete with each other in the Biotechnology sector. We will ...
-
Athenex, Inc. (ATNX) Declines A lot Today, Is Now One of The Worst Performer - Invest Tribune
Posted: May 1st, 2019, 6:28pm GMT
Athenex, Inc. (ATNX) Declines A lot Today, Is Now One of The Worst Performer Invest TribuneThe stock of Athenex, Inc. (NASDAQ:ATNX) is a huge mover today! The stock decreased 4.45% or $0.44 during the last trading session, reaching $9.44. About.
-
Athenex, Inc. (ATNX) Reaches $9.50 After 4.00% Down Move; 0 Bullish Analysts Covering Arrow Electronics, Inc. (ARW) - CryptoCoinsTribune
Posted: May 1st, 2019, 5:44pm GMT
Athenex, Inc. (ATNX) Reaches $9.50 After 4.00% Down Move; 0 Bullish Analysts Covering Arrow Electronics, Inc. (ARW) CryptoCoinsTribuneThe stock of Athenex, Inc. (NASDAQ:ATNX) is a huge mover today! The stock decreased 3.85% or $0.38 during the last trading session, reaching $9.5.
-
TRACON Pharmaceuticals, Inc. (TCON) Analysts See $-0.17 EPS - Invest Tribune
Posted: May 1st, 2019, 2:07pm GMT
TRACON Pharmaceuticals, Inc. (TCON) Analysts See $-0.17 EPS Invest TribuneAnalysts expect TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) to report $-0.17 EPS on May, 8.They anticipate $0.29 EPS change or 63.04 % from last ...
-
TRACON Pharmaceuticals Inc. (TCON) and Evogene Ltd. (NASDAQ:EVGN) Comparing side by side - CryptoCoinsTribune
Posted: May 1st, 2019, 6:16am GMT
TRACON Pharmaceuticals Inc. (TCON) and Evogene Ltd. (NASDAQ:EVGN) Comparing side by side CryptoCoinsTribuneWe are comparing TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Evogene Ltd. (NASDAQ:EVGN) on their dividends, analyst recommendations, ...
-
Analysts Anticipate TRACON Pharmaceuticals Inc (TCON) Will Post Earnings of -$0.19 Per Share - Tech Know Bits
Posted: April 30th, 2019, 9:15pm GMT
Analysts Anticipate TRACON Pharmaceuticals Inc (TCON) Will Post Earnings of -$0.19 Per Share Tech Know BitsBrokerages predict that TRACON Pharmaceuticals Inc (NASDAQ:TCON) will report ($0.19) earnings per share for the current fiscal quarter, according to Zacks.
-
TRACON Pharmaceuticals Inc. (TCON) and DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Contrasting side by side - CryptoCoinsTribune
Posted: April 30th, 2019, 7:24pm GMT
TRACON Pharmaceuticals Inc. (TCON) and DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Contrasting side by side CryptoCoinsTribuneTRACON Pharmaceuticals Inc. (NASDAQ:TCON) and DiaMedica Therapeutics Inc. (NASDAQ:DMAC), both competing one another are Biotechnology ...
-
EPS for TRACON Pharmaceuticals, Inc. (TCON) Expected At $-0.17 - The MAK Daily
Posted: April 30th, 2019, 2:28pm GMT
EPS for TRACON Pharmaceuticals, Inc. (TCON) Expected At $-0.17 The MAK DailyAnalysts expect TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) to report $-0.17 EPS on May, 8.They anticipate $0.29 EPS change or 63.04 % from last ...
-
TRACON Pharmaceuticals, Inc. (TCON) EPS Estimated At $-0.17 - Invest Tribune
Posted: April 30th, 2019, 2:27pm GMT
TRACON Pharmaceuticals, Inc. (TCON) EPS Estimated At $-0.17 Invest TribuneAnalysts expect TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) to report $-0.17 EPS on May, 8.They anticipate $0.29 EPS change or 63.04 % from last ...
-
Angiosarcomas Treatment Market Analysis and Emerging Growth, Forecast 2018-2026 - Business Herald
Posted: April 30th, 2019, 1:30pm GMT
Angiosarcomas Treatment Market Analysis and Emerging Growth, Forecast 2018-2026 Business HeraldThe Angiosarcomas Treatment Market research guide expresses every aspect and examines the market and upcoming opportunities of the industry. The report ...
-
"Count Me In" Project May Hold Promise For Mesothelioma Research - Mesothelioma.net Blog
Posted: April 30th, 2019, 1:11pm GMT
"Count Me In" Project May Hold Promise For Mesothelioma Research Mesothelioma.net BlogIn the quest to find a cure for malignant mesothelioma, one of the biggest obstacles that researchers encounter is the lack of patient sample information available ...
-
Could Athenex Inc (NASDAQ:ATNX) Go Down After Its Newest Short Interest Report? - Invest Tribune
Posted: April 29th, 2019, 3:40pm GMT
Could Athenex Inc (NASDAQ:ATNX) Go Down After Its Newest Short Interest Report? Invest TribuneThe stock of Athenex Inc (NASDAQ:ATNX) registered a decrease of 2.6% in short interest. ATNX's total short interest was 5.60 million shares in April as.
-
Athenex, Inc. (ATNX) Reaches $10.44 After 9.00% Down Move; Calithera Biosciences Has 1.06 Sentiment - The EN Herald
Posted: April 29th, 2019, 3:11pm GMT
Athenex, Inc. (ATNX) Reaches $10.44 After 9.00% Down Move; Calithera Biosciences Has 1.06 Sentiment The EN HeraldThe stock of Athenex, Inc. (NASDAQ:ATNX) is a huge mover today! The stock decreased 2.66% or $0.28 during the last trading session, reaching $10.44.
-
Could Tracon Pharmaceuticals Inc (NASDAQ:TCON) Skyrocket? The Stock Has Too Many Sellers - Invest Tribune
Posted: April 28th, 2019, 5:25pm GMT
Could Tracon Pharmaceuticals Inc (NASDAQ:TCON) Skyrocket? The Stock Has Too Many Sellers Invest TribuneThe stock of Tracon Pharmaceuticals Inc (NASDAQ:TCON) registered an increase of 73.68% in short interest. TCON's total short interest was 430200 shares in.
-
Angiosarcomas Treatment Market 2018 Growth, Industry Demand, Trends, Forecast 2018-2026 - Gator Ledger
Posted: April 28th, 2019, 1:30pm GMT
Angiosarcomas Treatment Market 2018 Growth, Industry Demand, Trends, Forecast 2018-2026 Gator LedgerThe “Angiosarcomas Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2018–2026” report serves with all-inclusive, ...
-
Can TRACON Pharmaceuticals, Inc. (TCON)'s Tomorrow be Different? The Stock Formed a Double Bottom Pattern - Invest Tribune
Posted: April 28th, 2019, 9:30am GMT
Can TRACON Pharmaceuticals, Inc. (TCON)'s Tomorrow be Different? The Stock Formed a Double Bottom Pattern Invest TribuneThe chart of TRACON Pharmaceuticals, Inc. (TCON) shows a double bottom with $0.64 target or 3.00 % below today's $0.66 share price. The 8 months chart ...
-
Zacks: Analysts Expect TRACON Pharmaceuticals Inc (TCON) Will Announce Earnings of -$0.19 Per Share - Rockland Register
Posted: April 28th, 2019, 5:00am GMT
Zacks: Analysts Expect TRACON Pharmaceuticals Inc (TCON) Will Announce Earnings of -$0.19 Per Share Rockland RegisterAnalysts expect TRACON Pharmaceuticals Inc (NASDAQ:TCON) to report earnings of ($0.19) per share for the current fiscal quarter, according to Zacks.
-
Analysts See $-0.17 EPS for TRACON Pharmaceuticals, Inc. (TCON) - Invest Tribune
Posted: April 27th, 2019, 3:08pm GMT
Analysts See $-0.17 EPS for TRACON Pharmaceuticals, Inc. (TCON) Invest TribuneAnalysts expect TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) to report $-0.17 EPS on May, 8.They anticipate $0.29 EPS change or 63.04 % from last ...
-
The New Frontier of Participatory Cancer Research - Popular Mechanics
Posted: April 26th, 2019, 3:22pm GMT
The New Frontier of Participatory Cancer Research Popular MechanicsA new cancer initiative hopes to expand the reach of rare cancer research from urban areas with major hospitals to pretty much everyone.
-
Athenex, Inc. (ATNX) Trades at $10.57 After Triangle; Arrowstreet Capital Limited Partnership Raised United Rentals (URI) Holding By $13.72 Million - The NBO News
Posted: April 26th, 2019, 9:21am GMT
Athenex, Inc. (ATNX) Trades at $10.57 After Triangle; Arrowstreet Capital Limited Partnership Raised United Rentals (URI) Holding By $13.72 Million The NBO NewsAthenex, Inc. (ATNX) formed triangle with $10.15 target or 4.00% below today's $10.57 share price. Athenex, Inc. (ATNX) has $708.44 million valuation.
-
TRACON Pharmaceuticals Inc (TCON) Expected to Announce Earnings of -$0.19 Per Share - Mayfield Recorder
Posted: April 26th, 2019, 9:21am GMT
TRACON Pharmaceuticals Inc (TCON) Expected to Announce Earnings of -$0.19 Per Share Mayfield RecorderWall Street brokerages forecast that TRACON Pharmaceuticals Inc (NASDAQ:TCON) will post earnings of ($0.19) per share for the current quarter, Zacks reports ...
-
Terry Ann Patten Vickers - Daily Herald
Posted: April 26th, 2019, 4:00am GMT
Terry Ann Patten Vickers Daily Herald1949-2019. Terry Ann Patten Vickers, 70, passed away on Monday, April 22, 2019, at the Summerfield Retirement Community in Orem, Utah. Terry Ann was a ...
-
Contrasting TRACON Pharmaceuticals (TCON) and Gilead Sciences (GILD) - Finance Daily
Posted: April 25th, 2019, 4:36pm GMT
Contrasting TRACON Pharmaceuticals (TCON) and Gilead Sciences (GILD) Finance DailyTRACON Pharmaceuticals (NASDAQ:TCON) and Gilead Sciences (NASDAQ:GILD) are both medical companies, but which is the superior stock? We will ...
-
Reviewing Solid Biosciences (SLDB) & TRACON Pharmaceuticals (TCON) - Mayfield Recorder
Posted: April 25th, 2019, 10:23am GMT
Reviewing Solid Biosciences (SLDB) & TRACON Pharmaceuticals (TCON) Mayfield RecorderSolid Biosciences (NASDAQ:SLDB) and TRACON Pharmaceuticals (NASDAQ:TCON) are both small-cap medical companies, but which is the superior business ...